Janus Henderson Group’s Amicus Therapeutics FOLD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$15.8M Sell
2,753,710
-567,443
-17% -$3.25M 0.01% 622
2025
Q1
$28M Sell
3,321,153
-73,905
-2% -$623K 0.02% 493
2024
Q4
$32M Sell
3,395,058
-2,940,177
-46% -$27.7M 0.02% 489
2024
Q3
$67.7M Sell
6,335,235
-6,896,159
-52% -$73.7M 0.03% 326
2024
Q2
$131M Sell
13,231,394
-583,120
-4% -$5.78M 0.07% 230
2024
Q1
$163M Buy
13,814,514
+2,307,385
+20% +$27.2M 0.09% 204
2023
Q4
$163M Sell
11,507,129
-3,426,892
-23% -$48.6M 0.1% 198
2023
Q3
$182M Buy
14,934,021
+10,433
+0.1% +$127K 0.12% 182
2023
Q2
$187M Buy
14,923,588
+1,313,153
+10% +$16.5M 0.12% 177
2023
Q1
$151M Sell
13,610,435
-84,114
-0.6% -$933K 0.1% 195
2022
Q4
$167M Sell
13,694,549
-15,857,681
-54% -$194M 0.12% 181
2022
Q3
$309M Buy
29,552,230
+12,772,089
+76% +$133M 0.12% 185
2022
Q2
$180M Buy
16,780,141
+1,157,528
+7% +$12.4M 0.12% 180
2022
Q1
$148M Buy
15,622,613
+5,764,732
+58% +$54.6M 0.07% 253
2021
Q4
$114M Buy
9,857,881
+2,803,673
+40% +$32.4M 0.05% 331
2021
Q3
$67.4M Buy
7,054,208
+2,065,621
+41% +$19.7M 0.03% 470
2021
Q2
$48.1M Sell
4,988,587
-3,995,468
-44% -$38.5M 0.02% 573
2021
Q1
$88.8M Sell
8,984,055
-2,263,153
-20% -$22.4M 0.04% 400
2020
Q4
$260M Sell
11,247,208
-2,859,051
-20% -$66M 0.12% 179
2020
Q3
$199M Buy
14,106,259
+2,312,500
+20% +$32.7M 0.1% 201
2020
Q2
$178M Buy
11,793,759
+167,835
+1% +$2.53M 0.1% 214
2020
Q1
$107M Buy
11,625,924
+867,308
+8% +$8.01M 0.07% 269
2019
Q4
$105M Sell
10,758,616
-187,619
-2% -$1.83M 0.05% 356
2019
Q3
$87.8M Buy
10,946,235
+73,256
+0.7% +$588K 0.05% 410
2019
Q2
$136M Sell
10,872,979
-183,163
-2% -$2.29M 0.07% 300
2019
Q1
$150M Sell
11,056,142
-17,442
-0.2% -$237K 0.08% 277
2018
Q4
$106M Buy
11,073,584
+2,267,225
+26% +$21.7M 0.07% 327
2018
Q3
$106M Buy
8,806,359
+627,972
+8% +$7.59M 0.06% 381
2018
Q2
$128M Sell
8,178,387
-367,952
-4% -$5.75M 0.07% 329
2018
Q1
$129M Buy
8,546,339
+629,638
+8% +$9.47M 0.08% 310
2017
Q4
$114M Buy
7,916,701
+482,387
+6% +$6.94M 0.07% 344
2017
Q3
$112M Buy
7,434,314
+407,304
+6% +$6.14M 0.07% 337
2017
Q2
$70.8M Buy
+7,027,010
New +$70.8M 0.05% 430